CoGenesis™ Neuro test is targeted genetic screening test for hereditary neurodegenerative diseases.
CoGenesis™ Neuro is designed to screen 462 neuro-related genes that associate with 199 neurodegenerative diseases. The genetic testing of neurodegenerative diseases is highly challenging due to genotype heterogeneity and overlapping clinical manifestations. Therefore, it is challenging to determine the exact disease based on clinical features only. The CoGenesisTM Neuro panel, coupled with next-generation sequencing, profiles the genetic variations in a large repertoire of neuro-related genes, which helps refine the diagnosis of neurodegenerative diseases. The test provides an accurate genetic variation profile with results within 6 weeks.
To improve and clarify the inheritance pattern of candidate results, it is recommended to also screen the parents of the affected patient.
CoGenesis™ Neuro is available from our partner’s clinics. Please contact us for more information.